Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis

• Antonia Lepida,

  Affiliation Liver Unit, Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium

  ⨯
• Massimo Colombo,

  Affiliation Department of Medicine, Division of Gastroenterology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Universita’ degli Studi di Milano, Milan, Italy

  ⨯
• Inmaculada Fernandez,

  Affiliation Hospital Universitario 12 de Octubre, Sección de Aparato Digestivo, Madrid, Spain

  ⨯
• Djamal Abdurakhmanov,

  Affiliation I.M. Sechenov First Moscow State Medical University, E.M. Tareev Clinic for Nephrology, Internal and Occupational Medicine, Moscow, Russia

  ⨯
• Paulo Abrao Ferreira,

  Affiliation Outpatient Clinic to HIV and Viral Hepatitis Division of Infectious Disease, Federal University of São Paulo, São Paulo, Brazil

  ⨯
• Simone I. Strasser,

  Affiliation AW Morrow Gastroenterology and Liver Center, Royal Prince Alfred hospital and University of Sydney, Sydney, Australia

  ⨯
• Petr Urbanek,

  Affiliation Department of Internal Medicine, First Medical Faculty, Charles University, and Central Military Hospital Prague, Prague, Czech Republic

  ⨯
• Alessandra Mangia,

  Affiliation Liver Unit, IRCCS Hospital 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, Italy

  ⨯
• José L. Calleja,

  Affiliation Gastroenterology, Hospital Universitario Puerta de Hierro, Universidad Autonoma de Madrid, CIBERehd, Madrid, Spain

  ⨯
• Wafae Iraqi,

  Affiliation Janssen Pharmaceuticals, Paris, France

  ⨯
• Ralph DeMasi,

  Affiliation Janssen Research and development, Titusville, New Jersey, United States of America

  ⨯
• Isabelle Lonjon-Domanec,

  Affiliation Janssen Pharmaceuticals, Paris, France

  ⨯
• Christophe Moreno ,

  Contributed equally to this work with: Christophe Moreno, Heiner Wedemeyer

  * E-mail: christophe.moreno@erasme.ulb.ac.be

  Affiliation Liver Unit, Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium

  ⨯
• Heiner Wedemeyer

  Contributed equally to this work with: Christophe Moreno, Heiner Wedemeyer

  Affiliation Medizinische Hochschule Hannover, Hannover, Germany

  ⨯